• [email protected]
  • +971 507 888 742
Submit Manuscript
SciAlert
  • Home
  • Journals
  • Information
    • For Authors
    • For Referees
    • For Librarian
    • For Societies
  • Contact
  1. Journal of Pharmacology and Toxicology
  2. Vol 2 (7), 2007
  3. 610-620
  • Online First
  • Current Issue
  • Previous Issues
  • More Information
    Aims and Scope Editorial Board Guide to Authors Article Processing Charges
    Submit a Manuscript

Journal of Pharmacology and Toxicology

Year: 2007 | Volume: 2 | Issue: 7 | Page No.: 610-620
DOI: 10.3923/jpt.2007.610.620

Facebook Twitter Digg Reddit Linkedin StumbleUpon E-mail

Article Trend



Total views 96

Authors


Omar M.E. Abdel Salam


Nabila S. Hassan


Ayman R. Baiuomy


Sawsan H. Karam


Keywords


  • amlodipine
  • carbon tetrachloride
  • Diltiazem
  • enalapril
  • hepatoprotective
Research Article

The Effect of Amlodipine, Diltiazem and Enalapril on Hepatic Injury Caused in Rats by the Administration of CCl4

Omar M.E. Abdel Salam, Nabila S. Hassan, Ayman R. Baiuomy and Sawsan H. Karam
The present study compared the effect of the calcium channel blockers amlodipine and diltiazem with the ACE inhibitor enalapril on CCl4-induced acute hepatic injury in rats. Amlodipine (0.9 or 1.8 mg kg-1), diltiazem (10.8 or 21.6 mg kg-1) and enalapril (0.9 or 1.8 mg kg-1) were administered per os daily for 7 days, then acute hepatic injury was induced by treating rats using a gavage with a single dose of CCl4-olive oil (1:1, 0.2 mL/100 g). Drug administration continued after CCl4 and the treated animals were killed on day 3 after CCl4 administration. Results indicated that whereas a reduction in serum enzyme levels of aspartate aminotransferase (AST), alanine aminotransferase (ALT) and alkaline phosphatase (ALP) was obtained with amlodipine and enalapril, no protective effect was observed for diltiazem in this model of hepatic injury. Thus, compared with the CCl4 control group, serum ALT decreased by 56.2-61.4 and AST by 16-25.1%, after the administration of amlodipine at 0.9 and 1.8 mg kg-1, respectively. Serum ALP was significantly reduced by 40% by 1.8 mg kg-1 amlodipine. Enalapril administered at 0.9 and 1.8 mg kg-1 significantly decreased ALT by 22.8-61.4%, while AST and ALP were significantly reduced by 37.3 and 54.5%, respectively by 1.8 mg kg-1 enalapril. In contrast, diltiazem administered at 20.4 mg kg-1 increased ALT and AST levels by 43 and 16%, respectively. Histologic examination of haematoxylin and eosin stained sections from the livers of rats treated with CCl4 and amlodipine showed prominent improvement in liver architecture, a decrease in inflammatory cells and necrotic area. Electron microscopic examination of hepatocytes of CCl4-treated rat showed disorganization of the cytoplasmic structure and degeneration of cytoplasmic organelles. Electron microscopy of hepatocytes from the rats treated with CCl4 + amlodipine revealed healthy cytoplasmic content with healthy nuclei and normal mitochondria. Similar findings were observed after enalapril treatment. In contrast, intensive necrosis and degeneration was seen in livers of rats treated with diltiazem. On electron microscopy in most of hepatocytes, the cytoplasm became lytic with distorted mitochondrial cristae and highly dilated endoplasmic reticulum. Thus two calcium channel blockers behaved differently as regards to hepatic injury in the model of CCl4-induced hepatic injury. It is suggested that profound haemodynamic effects of diltiazem which undergoes extensive hepatic metabolism and the resultant decrease in hepatic blood flow account for the observed effect of the drug.
PDF Fulltext XML References Citation

How to cite this article

Omar M.E. Abdel Salam, Nabila S. Hassan, Ayman R. Baiuomy and Sawsan H. Karam, 2007. The Effect of Amlodipine, Diltiazem and Enalapril on Hepatic Injury Caused in Rats by the Administration of CCl4 . Journal of Pharmacology and Toxicology, 2: 610-620.

DOI: 10.3923/jpt.2007.610.620

URL: https://scialert.net/abstract/?doi=jpt.2007.610.620

Related Articles

Influence of Selected Formulation Variables on the Preparation of Peptide Loaded Lipospheres
Formulation Optimization of Controlled Delivery System for Antihypertensive Peptide using Response Surface Methodology

Leave a Comment


Your email address will not be published. Required fields are marked *

Useful Links

  • Journals
  • For Authors
  • For Referees
  • For Librarian
  • For Socities

Contact Us

Office Number 1128,
Tamani Arts Building,
Business Bay,
Deira, Dubai, UAE

Phone: +971 507 888 742
Email: [email protected]

About Science Alert

Science Alert is a technology platform and service provider for scholarly publishers, helping them to publish and distribute their content online. We provide a range of services, including hosting, design, and digital marketing, as well as analytics and other tools to help publishers understand their audience and optimize their content. Science Alert works with a wide variety of publishers, including academic societies, universities, and commercial publishers.

Follow Us
© Copyright Science Alert. All Rights Reserved